All cancer types, Lung cancer, Non small cell lung cancer (NSCLC)
Results
Phase 1
This trial looked at whether ceritinib can stop the growth of cancers that have a change to a gene called ALK.
Recruitment start: 24 January 2011
Recruitment end: 26 July 2013
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Jeff Evans (UK)
Experimental Cancer Medicine Centre (ECMC)
Novartis
Last reviewed: 19 Dec 2017
CRUK internal database number: 7741
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Connect with other people affected by cancer and share your experiences.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
